e.g. Filippa Pettersson or Cancer Res. 75(6) , 1102-12, (2015) or 10.1002/anie.201600521
Shuttle–Cargo Fusion Molecules of Transport Peptides and the hD2/3 Receptor Antagonist Fallypride: A Feasible Approach To Preserve Ligand–Receptor Binding?
To determine if the conjugation of a small receptor ligand to a peptidic carrier to potentially facilitate transport across the blood–brain barrier (BBB) by “molecular Trojan horse” transcytosis is feasible, we synthesized several transport peptide–fallypride fusion